JeffreyArthurMahonMD

PubMed

• 48 citations
  A New Approach for Diagnosing Type 1 Diabetes in Autoantibody-Positive Individuals Based on Prediction and Natural History
  Jay M. Sosenko, Jay S. Skyler, Linda A. DiMeglio, Craig A. Beam, Jeffrey P. Krischer, Carla J. Greenbaum, David Boulware, Lisa E. Rafkin, Della Matheson, Kevan C. Hero...> ;Diabetes Care. 2015 Feb 1
• Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for improving the accuracy of the risk classification of type 1 diabetes.
  Sosenko JM, Skyler JS, Mahon J, Krischer JP, Greenbaum CJ, Rafkin LE, Beam CA, Boulware DC, Matheson D, Cuthbertson D, Herold KC, Eisenbarth G, Palmer JP> ;Diabetes Care. 2014-04-01
• 57 citations
  Acceleration of the Loss of the First-Phase Insulin Response During the Progression to Type 1 Diabetes in Diabetes Prevention Trial–Type 1 Participants
  Jay M. Sosenko, Jay S. Skyler, Craig A. Beam, Jeffrey P. Krischer, Carla J. Greenbaum, Jeffrey L. Mahon, Lisa E. Rafkin, Della Matheson, Kevan C. Herold, Jerry P. Palmer> ;Diabetes. 2013 Dec 1
• 82 citations
  The Prediction of Type 1 Diabetes by Multiple Autoantibody Levels and Their Incorporation Into an Autoantibody Risk Score in Relatives of Type 1 Diabetic Patients
  Jay M. Sosenko, Jay S. Skyler, Jerry P. Palmer, Jeffrey P. Krischer, Liping Yu, Jeffrey L. Mahon, Craig A. Beam, David Boulware, Lisa E. Rafkin, Desmond A. Schatz, Geo...> ;Diabetes Care. 2013 Jul 1
• The Application of the Diabetes Prevention Trial-Type 1 Risk Score for Identifying a Preclinical State of Type 1 Diabetes.
  Sosenko, J. M., Skyler, J. S., Mahon, J., Krischer, J. P., Beam, C. A., Boulware, D. C., Greenbaum, C. J., Rafkin, L. E., Cowie, C., Cuthbertson, D., Palmer, J. P.> ;Diabetes Care. 2012 Jul
• Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study.
  Sosenko JM, Skyler JS, Mahon J, Krischer JP, Beam CA, Boulware DC, Greenbaum CJ, Rafkin LE, Cowie C, Cuthbertson D, Palmer JP> ;Diabetes Care. 2011-08-01
• Glucose excursions between states of glycemia with progression to type 1 diabetes in the diabetes prevention trial-type 1 (DPT-1).
  Sosenko JM, Skyler JS, Krischer JP, Greenbaum CJ, Mahon J, Rafkin LE, Cuthbertson D, Cowie C, Herold K, Eisenbarth G, Palmer JP> ;Diabetes. 2010-10-01
• A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type 1.
  Sosenko JM, Krischer JP, Palmer JP, Mahon J, Cowie C, Greenbaum CJ, Cuthbertson D, Lachin JM, Skyler JS> ;Diabetes Care. 2008-03-01
• Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabe...
  Sosenko JM, Palmer JP, Greenbaum CJ, Mahon J, Cowie C, Krischer JP, Chase HP, White NH, Buckingham B, Herold KC, Cuthbertson D, Skyler JS> ;Diabetes Care. 2007-01-01
• Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1.
  Sosenko JM, Palmer JP, Greenbaum CJ, Mahon J, Cowie C, Krischer JP, Chase HP, White NH, Buckingham B, Herold KC, Cuthbertson D, Skyler JS> ;Diabetes Care. 2006-03-01
• Natural course of remission in IDDM during 1st yr after diagnosis.
  Martin S, Pawlowski B, Greulich B, Ziegler AG, Mandrup-Poulsen T, Mahon J> ;Diabetes Care. 1992-01-01
• Clinical trials of cyclosporin in IDDM.
  Dupré J, Stiller CR, Gent M, Donner A, von Graffenried B, Heinrichs D, Jenner M, Keown P, Mahon J, Martell R> ;Diabetes Care. 1988-01-01
• Join now to see all